{"id":"https://openalex.org/W2554782823","doi":"https://doi.org/10.1183/13993003.congress-2016.pa985","title":"Efficacy of indacaterol/glycopyrronium (IND/GLY) versus salmeterol/fluticasone (SFC) on exacerbations and health status in GOLD Group D COPD patients: The FLAME study","display_name":"Efficacy of indacaterol/glycopyrronium (IND/GLY) versus salmeterol/fluticasone (SFC) on exacerbations and health status in GOLD Group D COPD patients: The FLAME study","publication_year":2016,"publication_date":"2016-09-01","ids":{"openalex":"https://openalex.org/W2554782823","doi":"https://doi.org/10.1183/13993003.congress-2016.pa985","mag":"2554782823"},"language":"en","primary_location":{"id":"doi:10.1183/13993003.congress-2016.pa985","doi":"https://doi.org/10.1183/13993003.congress-2016.pa985","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2016.pa985","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"5.1 Airway Pharmacology and Treatment","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5105193942","display_name":"Michael Larbig","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Paul Michael Larbig","raw_affiliation_strings":["Respiratory, Novartis Pharma AG"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Respiratory, Novartis Pharma AG","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059684830","display_name":"Claus Franz Vogelmeier","orcid":"https://orcid.org/0000-0002-9798-2527","observed_orcids":["https://orcid.org/0000-0002-9798-2527"]},"institutions":[{"id":"https://openalex.org/I268975460","display_name":"Universit\u00e4tsklinikum Gie\u00dfen und Marburg","ror":"https://ror.org/032nzv584","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I268975460"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Claus Vogelmeier","raw_affiliation_strings":["Dept of Medicine, Pulmonary and Critical Care Medicine, Universit\u00e4tsklinikum Gie\u00dfen und Marburg"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept of Medicine, Pulmonary and Critical Care Medicine, Universit\u00e4tsklinikum Gie\u00dfen und Marburg","institution_ids":["https://openalex.org/I268975460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001192345","display_name":"Nicol\u00e1s Roche","orcid":"https://orcid.org/0000-0002-3162-5033","observed_orcids":["https://orcid.org/0000-0002-3162-5033"]},"institutions":[{"id":"https://openalex.org/I4210092774","display_name":"H\u00f4pital Cochin","ror":"https://ror.org/00ph8tk69","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210092774","https://openalex.org/I4210097159","https://openalex.org/I4210124464"]},{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4387156284","display_name":"Universit\u00e9 Paris Descartes","ror":"https://ror.org/0220k9r37","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I4387156284"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Nicolas Roche","raw_affiliation_strings":["Respiratory and Intensive Care Medicine, Cochin Hospital Group, AP-HP, University Paris Descartes"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Respiratory and Intensive Care Medicine, Cochin Hospital Group, AP-HP, University Paris Descartes","institution_ids":["https://openalex.org/I4210092774","https://openalex.org/I4210097159","https://openalex.org/I4387156284"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065554413","display_name":"Tim S. Ayers","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]},{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["CH","US"],"is_corresponding":false,"raw_author_name":"Tim Ayers","raw_affiliation_strings":["Respiratory, Novartis Pharmaceuticals Corporation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Respiratory, Novartis Pharmaceuticals Corporation","institution_ids":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072735506","display_name":"Angel FowlerTaylor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]},{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["CH","US"],"is_corresponding":false,"raw_author_name":"Angel FowlerTaylor","raw_affiliation_strings":["Respiratory, Novartis Pharmaceuticals Corporation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Respiratory, Novartis Pharmaceuticals Corporation","institution_ids":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054694856","display_name":"Chau T. Thach","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]},{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["CH","US"],"is_corresponding":false,"raw_author_name":"Chau Thach","raw_affiliation_strings":["Respiratory, Novartis Pharmaceuticals Corporation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Respiratory, Novartis Pharmaceuticals Corporation","institution_ids":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005436931","display_name":"Anupama Shrinivasan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Anupama Shrinivasan","raw_affiliation_strings":["Respiratory, Novartis Healthcare Pvt. Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Respiratory, Novartis Healthcare Pvt. Ltd","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036976413","display_name":"Robert Fogel","orcid":"https://orcid.org/0000-0002-1441-0962","observed_orcids":["https://orcid.org/0000-0002-1441-0962"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]},{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["CH","US"],"is_corresponding":false,"raw_author_name":"Robert Fogel","raw_affiliation_strings":["Respiratory, Novartis Pharmaceuticals Corporation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Respiratory, Novartis Pharmaceuticals Corporation","institution_ids":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085245138","display_name":"Francesco Patalano","orcid":"https://orcid.org/0000-0001-7015-6084","observed_orcids":["https://orcid.org/0000-0001-7015-6084"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Francesco Patalano","raw_affiliation_strings":["Respiratory, Novartis Pharma AG"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Respiratory, Novartis Pharma AG","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113693947","display_name":"Donald D. Banerji","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]},{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["CH","US"],"is_corresponding":false,"raw_author_name":"Donald Banerji","raw_affiliation_strings":["Respiratory, Novartis Pharmaceuticals Corporation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Respiratory, Novartis Pharmaceuticals Corporation","institution_ids":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"PA985","last_page":"PA985"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-obstructive-pulmonary-disease","display_name":"chronic obstructive pulmonary disease","score":0.6769999861717224},{"id":"https://openalex.org/keywords/indacaterol-glycopyrronium","display_name":"indacaterol/glycopyrronium","score":0.9649999737739563},{"id":"https://openalex.org/keywords/salmeterol-fluticasone","display_name":"salmeterol/fluticasone","score":0.9950000047683716},{"id":"https://openalex.org/keywords/acute-exacerbation-of-copd","display_name":"COPD exacerbations","score":0.8700000047683716},{"id":"https://openalex.org/keywords/laba-lama","display_name":"LAMA/LABA","score":0.6579999923706055},{"id":"https://openalex.org/keywords/laba-ics","display_name":"LABA/ICS","score":0.9810000061988831},{"id":"https://openalex.org/keywords/health-status","display_name":"health status","score":0.6919999718666077},{"id":"https://openalex.org/keywords/st-george-s-respiratory-questionnaire","display_name":"St George's Respiratory Questionnaire","score":0.9319999814033508},{"id":"https://openalex.org/keywords/severe-copd","display_name":"severe COPD","score":0.4480000138282776},{"id":"https://openalex.org/keywords/bronchodilator-therapy","display_name":"bronchodilator therapy","score":0.6340000033378601}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9407016038894653},{"id":"https://openalex.org/C2776780178","wikidata":"https://www.wikidata.org/wiki/Q199804","display_name":"COPD","level":2,"score":0.823051929473877},{"id":"https://openalex.org/C2777014857","wikidata":"https://www.wikidata.org/wiki/Q1383410","display_name":"Exacerbation","level":2,"score":0.7905203700065613},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6863558292388916},{"id":"https://openalex.org/C2778884479","wikidata":"https://www.wikidata.org/wiki/Q425654","display_name":"Indacaterol","level":4,"score":0.629015326499939},{"id":"https://openalex.org/C2776719499","wikidata":"https://www.wikidata.org/wiki/Q424333","display_name":"Salmeterol","level":3,"score":0.5844618082046509},{"id":"https://openalex.org/C2777785397","wikidata":"https://www.wikidata.org/wiki/Q492194","display_name":"Group B","level":2,"score":0.5747369527816772},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.5584895014762878},{"id":"https://openalex.org/C40993552","wikidata":"https://www.wikidata.org/wiki/Q514654","display_name":"Gold standard (test)","level":2,"score":0.5446407794952393},{"id":"https://openalex.org/C2781212218","wikidata":"https://www.wikidata.org/wiki/Q1002165","display_name":"Fluticasone","level":3,"score":0.46091607213020325},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.32914531230926514},{"id":"https://openalex.org/C2776804153","wikidata":"https://www.wikidata.org/wiki/Q210420","display_name":"Corticosteroid","level":2,"score":0.13523036241531372},{"id":"https://openalex.org/C2776042228","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma","level":2,"score":0.09100106358528137},{"id":"https://openalex.org/C2781018748","wikidata":"https://www.wikidata.org/wiki/Q927234","display_name":"Bronchodilator","level":3,"score":0.07753100991249084}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1183/13993003.congress-2016.pa985","doi":"https://doi.org/10.1183/13993003.congress-2016.pa985","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2016.pa985","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"5.1 Airway Pharmacology and Treatment","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2555287152","https://openalex.org/W2550392040","https://openalex.org/W2791853267","https://openalex.org/W2553178635","https://openalex.org/W2549238402","https://openalex.org/W2550562511","https://openalex.org/W2550623081","https://openalex.org/W2564473194","https://openalex.org/W2776174504","https://openalex.org/W2579315308"],"abstract_inverted_index":{"Introduction":[0],"According":[1],"to":[2,12,78,93],"current":[3],"GOLD":[4,26,121,132,204],"strategy":[5],"combined":[6],"COPD":[7,62,81,88,196,207],"assessment,":[8],"patients":[9,63,82,167],"with":[10,47,64,83,144,168],"severe":[11,14,80,109],"very":[13,79],"COPD,":[15],"high":[16],"risk":[17,66],"of":[18,45,67,85,103,142,166,195],"exacerbations":[19,46,143,197],"and":[20,95,106,111,198],"more":[21],"symptoms":[22],"are":[23,30],"categorised":[24],"into":[25],"Group":[27,122,133,205],"D.":[28,134],"They":[29],"recommended":[31],"LABA/ICS":[32],"and/or":[33],"LAMA":[34],"as":[35],"first":[36],"choice":[37],"therapy.":[38],"The":[39],"FLAME":[40],"study":[41,74],"evaluated":[42,99],"the":[43,193,200],"rate":[44,102,141,194],"a":[48,55,65,137,171],"LABA/LAMA,":[49],"IND/GLY":[50,94,145,148,169,185],"110/50":[51],"\u00b5g":[52,59],"o.d.":[53],"vs":[54,146,157,179],"LABA/ICS,":[56],"SFC":[57,158,180,190],"50/500":[58],"b.i.d.":[60],"in":[61,90,101,113,120,140,153,175,191,203],"exacerbation.":[68],"Methods":[69],"This":[70],"52-week,":[71],"multicentre,":[72],"double-blind":[73],"randomised":[75,128],"(1:1)":[76],"moderate":[77,107],"history":[84],"\u22651":[86],"moderate-severe":[87],"exacerbation":[89],"prior":[91],"year,":[92],"SFC.":[96,147],"Here,":[97],"we":[98],"reduction":[100,139],"all":[104],"(mild/moderate/severe)":[105],"or":[108],"exacerbations,":[110],"improvement":[112,152,174],"health":[114,201],"status":[115,202],"using":[116],"SGRQ-C":[117,154,176],"total":[118,155,177],"score":[119,156,178],"D":[123,206],"patients.":[124,208],"Results":[125],"Of":[126],"3362":[127],"patients,":[129],"74.8%":[130],"were":[131],"There":[135],"was":[136],"significant":[138,151],"showed":[149,170,186],"statistically":[150],"from":[159],"Week":[160],"12":[161],"onwards.":[162],"Also,":[163],"higher":[164],"proportion":[165],"clinically":[172],"meaningful":[173],"(odds":[181],"ratio:1.32,":[182],"p=0.002).":[183],"Conclusion":[184],"superior":[187],"efficacy":[188],"than":[189],"reducing":[192],"improving":[199]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-11-30T00:00:00"}